01
Mar 2022
Sickle cell patients have started to receive the first new treatment for the blood disorder in over twenty years. The drug, Crizanlizumab, is given as a monthly infusion and is believed to reduce A&E visits by 40 per cent. Sickle cell disease can cause severe pain and organ failure, often requiring hospital admissions. It…
01
Mar 2022
Currently, tests to detect genes that increase cancer risk are only available to people with a family history of the disease and following a referral from a GP. However, the Institute of Cancer Research says the criteria should be widened to include more patients. The team found that almost half of people with a…
28
Feb 2022
For many parents divorcing/separating the question of how to maintain ongoing payments for private school fees is understandably a huge and immediate concern. For children whose parents are separating, staying in their usual school environment with their friends and familiar routines can be a source of comfort and support. Being forced to immediately move…
22
Feb 2022
Leading cancer doctors are undertaking research that may lead to the most radical shake-up of the NHS breast screening programme since its launch over 30 years ago. Trials have been launched in an effort to remedy long-standing concerns that the system is prone to false alarms and missed diagnoses in some cases. Although…
22
Feb 2022
A test which spots the most dangerous prostate cancer tumours has been developed by doctors. Current methods mean that differentiating between aggressive and harmless prostate tumours is difficult, especially at an early stage. For some men, the tumour may grow slowly and never cause problems, whilst for some men the tumour can be lethal.…
22
Feb 2022
US scientists have discovered a way of editing the genes of ticks, opening the possibility to researchers being able to alter parts of their DNA that helps them carry and transmit the disease-causing bacteria. In a similar tactic to that used on mosquitos as part of trials to reduce the spread of malaria, the…
© Copyright 2025. Website design by Fantastic Media.
*The following are trading names/styles of Chadwick Lawrence LLP, Chadwick Lawrence Solicitors, Chadwick Lawrence, Yorkshire’s Legal People, Chadlaw, Acclaim
